Registered entities
INOZYME PHARMA, INC.
Reg. No. 1693011United States
Inozyme Pharma, Inc.
Reg. No. 001t000000WoJL2AANUnited States
Innovation
16 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 705 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 9 |
| 2025 | 8 |
| 2026 | 2 |
Investor mix
12 investors on record; lead investors include Longitude Capital, Sofinnova Investments, Pivotal bioVenture Partners; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 42% |
| Private equity | 1 | 8% |
| Bank & private debt | 2 | 17% |
| Other / undisclosed | 4 | 33% |